Nucleic acid sequencing technologies have transformed the genetics and diagnostics fields, from the first Sanger sequencing of the human genome to whole population studies using the latest NGS technologies.
Genome sequencing allows disease diagnosis at an earlier stage and with the discovery of relevant biomarkers it means that more targeted therapeutic interventions can be provided. The trend towards a more personalized approach to healthcare is one reason for the continued growth in molecular diagnostics.
From infectious diseases and cancers to metabolic disorders and cardiac health, immunodiagnostics provides highly sensitive and specific insights into a wide range of conditions, enabling the development of specific treatments and therapies.
Our custom biology, conjugation, contract manufacturing and Lyo-Stable solutions can be tailored to your needs, enabling faster commercialization of your assay with minimal disruption to your existing protocols.
